Stock BIOV BIO-VIEW LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bio-View Ltd

Equities

BIOV

IL0010960495

Advanced Medical Equipment & Technology

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 15:24:51 20/05/2024 BST 		5-day change 1st Jan Change
28.7 ILa 0.00% Intraday chart for Bio-View Ltd -0.35% -12.77%
03-27 Bio-View Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-27 Bio-View Ltd announces an Equity Buyback for ILS 0.7 million worth of its shares. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 31.86 43.16 56.04 44.79 50.66 45.53
Enterprise Value (EV) 1 13.85 26.9 40.27 30.18 35.28 31.92
P/E ratio -17.1 x 17.1 x 66.8 x 20.9 x 87.6 x 116 x
Yield - - - - - -
Capitalization / Revenue 1.26 x 1.21 x 2.16 x 1.47 x 1.74 x 1.31 x
EV / Revenue 0.55 x 0.75 x 1.55 x 0.99 x 1.21 x 0.92 x
EV / EBITDA -6.76 x 5.71 x 22.1 x 10.9 x 97.2 x 70 x
EV / FCF -97.7 x 13.6 x 81.4 x 19.7 x 69.1 x -101 x
FCF Yield -1.02% 7.37% 1.23% 5.07% 1.45% -0.99%
Price to Book 1.4 x 1.73 x 2.19 x 1.65 x 1.81 x 1.59 x
Nbr of stocks (in thousands) 141,970 142,054 139,760 137,026 137,026 138,396
Reference price 2 0.2244 0.3038 0.4010 0.3269 0.3697 0.3290
Announcement Date 13/03/19 22/03/20 21/03/21 24/03/22 27/03/23 27/03/24
1ILS in Million2ILS
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 25.28 35.79 25.96 30.51 29.14 34.77
EBITDA 1 -2.049 4.714 1.82 2.771 0.363 0.456
EBIT 1 -2.59 4.358 1.665 2.557 0.103 0.137
Operating Margin -10.25% 12.18% 6.41% 8.38% 0.35% 0.39%
Earnings before Tax (EBT) 1 -1.826 3.368 1.141 2.683 0.875 0.797
Net income 1 -1.854 2.525 0.884 2.184 0.587 0.383
Net margin -7.33% 7.06% 3.41% 7.16% 2.01% 1.1%
EPS 2 -0.0131 0.0178 0.006000 0.0156 0.004220 0.002828
Free Cash Flow 1 -0.1418 1.981 0.4949 1.531 0.5109 -0.3158
FCF margin -0.56% 5.54% 1.91% 5.02% 1.75% -0.91%
FCF Conversion (EBITDA) - 42.03% 27.19% 55.26% 140.74% -
FCF Conversion (Net income) - 78.47% 55.98% 70.11% 87.03% -
Dividend per Share - - - - - -
Announcement Date 13/03/19 22/03/20 21/03/21 24/03/22 27/03/23 27/03/24
1ILS in Million2ILS
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 18 16.3 15.8 14.6 15.4 13.6
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.14 1.98 0.49 1.53 0.51 -0.32
ROE (net income / shareholders' equity) -8.03% 10.6% 3.53% 8.36% 2.12% 1.38%
ROA (Net income/ Total Assets) -4.75% 7.74% 2.94% 4.32% 0.16% 0.2%
Assets 1 39.01 32.63 30.1 50.5 373.6 187.7
Book Value Per Share 2 0.1600 0.1800 0.1800 0.2000 0.2000 0.2100
Cash Flow per Share 2 0.1300 0.1300 0.1300 0.1400 0.1400 0.1200
Capex 1 0.18 0.21 0.3 0.66 0.46 0.27
Capex / Sales 0.71% 0.58% 1.17% 2.16% 1.57% 0.79%
Announcement Date 13/03/19 22/03/20 21/03/21 24/03/22 27/03/23 27/03/24
1ILS in Million2ILS
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Diagnostic & Testing Equipment

1st Jan change Capi.
BIO-VIEW LTD Stock Bio-View Ltd
-12.77% 10.17M
SARTORIUS AG Stock Sartorius AG
-18.97% 18.12B
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-42.48% 2.87B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+22.69% 1.9B
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-1.56% 1.65B
BIOTAGE AB Stock Biotage AB
+32.98% 1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-17.41% 957M
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-22.25% 896M
REVENIO GROUP OYJ Stock Revenio Group Oyj
+10.31% 841M
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-26.78% 612M
Medical Diagnostic & Testing Equipment
  1. Stock Market
  2. Equities
  3. BIOV Stock
  4. Financials Bio-View Ltd